Works matching IS 13982273 AND DT 2001 AND VI 3 AND IP 2

Results: 10

The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach.

Published in:

Transplant Infectious Disease, 2001, v. 3, n. 2, p. 88, doi. 10.1034/j.1399-3062.2001.003002088.x

By:

Nalesnik, M.A.

Publication type:

Article

The role of antiviral and immunoglobulin therapy in the prevention of Epstein–Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.

Published in:

Transplant Infectious Disease, 2001, v. 3, n. 2, p. 97, doi. 10.1034/j.1399-3062.2001.003002097.x

By:

Green, Michael;
Reyes, Jorge;
Webber, Steven;
Rowe, David

Publication type:

Article

Anti-B cell and anti-cytokine therapy for the treatment of post-transplant lymphoproliferative disorder: past, present, and future.

Published in:

Transplant Infectious Disease, 2001, v. 3, n. 2, p. 104, doi. 10.1034/j.1399-3062.2001.003002104.x

By:

Durandy, A.

Publication type:

Article

Interferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder.

Published in:

Transplant Infectious Disease, 2001, v. 3, n. 2, p. 108, doi. 10.1034/j.1399-3062.2001.003002108.x

By:

Davis, Connie L.

Publication type:

Article

Recurrent Epstein–Barr virus associated disease in a cardiac transplant patient: evolution from plasmacytic hyperplasia to diffuse large cell lymphoma.

Published in:

Transplant Infectious Disease, 2001, v. 3, n. 2, p. 119, doi. 10.1034/j.1399-3062.2001.003002119.x

By:

Larratt, L.M.;
Hamilton, M.;
Coupland, R.;
Preiksaitis, J.K.

Publication type:

Article

Editorial.

Published in:

2001

By:

Rubin, R.H.

Publication type:

Editorial

Epstein–Barr virus infection and malignancy in solid organ transplant recipients: strategies for prevention and treatment.

Published in:

2001

By:

Preiksaitis, J.K.

Publication type:

Editorial

The Epstein–Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.

Published in:

Transplant Infectious Disease, 2001, v. 3, n. 2, p. 60, doi. 10.1034/j.1399-3062.2001.003002060.x

By:

Tanner, J.E.;
Alfieri, C.

Publication type:

Article

Identifying the patient at risk for post-transplant lymphoproliferative disorder.

Published in:

Transplant Infectious Disease, 2001, v. 3, n. 2, p. 70, doi. 10.1034/j.1399-3062.2001.003002070.x

By:

Cockfield, S.M.

Publication type:

Article

Epstein–Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease.

Published in:

Transplant Infectious Disease, 2001, v. 3, n. 2, p. 79, doi. 10.1034/j.1399-3062.2001.003002079.x

By:

Rowe, D.T.;
Webber, S.;
Schauer, E.M.;
Reyes, J.;
Green, M.

Publication type:

Article